| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.077 | 0.008 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.008 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.087 | 0.008 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.09 | 0.008 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |